Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

University of Washington Selects New LIMS for Large-Scale Next Generation Sequencing Center

Published: Tuesday, November 16, 2010
Last Updated: Tuesday, November 16, 2010
Bookmark and Share
GenoLogics have announced that the University of Washington, Genome Sciences Genomics Resource Center (GS-GRC), has selected Geneus, the GenoLogics lab information and genomics data management system, for its next generation sequencing center.

The University of Washington GS-GRC intends to scale to approximately eighteen Genome Analyzers over the next few months and, in order to make the most of this investment, investigators realized they required a commercial Lab Information Management System (LIMS).

The requirements for a LIMS that would suit the center included:

• The ability to handle high volume of next generation sequencing data in a high throughput center
• End-to-end lab information management functionality
• Reliable and comprehensive sample tracking capabilities
• A short time frame to get from installation to production
• An existing integration to Illumina’s Genome Analyzer
• An ability to scale and adapt as technologies and workflows change

“We had to feel confident that the system we chose for our next generation sequencing center could be deployed on an accelerated timeline, while maintaining the ability to adapt to constantly evolving next generation sequencing technology and workflows. We chose Geneus from GenoLogics, and we have been processing samples for several months with no interruptions,” said Dr. Mark Rieder, principal investigator at the GS-GRC.

The GenoLogics solution is currently installed, and within two months from the installation date it was ensuring sample traceability. GenoLogics is working closely with the University of Washington bioinformatics team to enable users with Application Programming Interfaces (APIs). With these APIs and some guidance from GenoLogics, the team has been able to accelerate their implementation and adoption timeline significantly, and increase the overall value users can extract from the system.

Geneus is a highly configurable and flexible lab information and data management system that supports workflows across multiple technology platforms including next generation sequencing instruments. It provides genomics facilities with an end-to-end solution, from sample and workflow management to automating pipelines, and consolidation of data to enable analysis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GenoLogics Releases Clarity LIMS X as Part of Illumina SeqLab
Provides positive sample tracking, maximizes quality and throughput in population-scale genomics workflows.
Friday, July 31, 2015
GenoLogics Announces Expansion
Genomics informatics leader opens new office and bolsters hiring in response to demand for its products and services.
Saturday, February 28, 2015
GenomeDx Biosciences Implements Clarity LIMS for use in Clinical Lab
LIMS to support Decipher® Test for personalizing treatment for prostate cancer patients.
Wednesday, January 28, 2015
Frost & Sullivan Recognizes the High Value GenoLogics Offers its Customers
The superior quality Web interface and tool kits of the company’s LIMS solution have set an industry benchmark.
Wednesday, January 28, 2015
GenoLogics to Provide Illumina with LIMS for HiSeq X Ten System
GenoLogics has been selected by Illumina as the preferred laboratory information management system (LIMS) provider to support HiSeq X Ten sequencing system customers.
Thursday, September 04, 2014
GenoLogics Announces Availability of Clarity LIMS 3.1
New features bolster support for compliance in clinical environments.
Thursday, August 07, 2014
SciLifeLab Implements Genologics Clarity LIMS
One of Europe's largest genomics labs uses Clarity LIMS to support cutting edge sequencing services for Swedish researchers
Saturday, February 15, 2014
Personalis Selects Clarity LIMS, Citing Quick Deployment as Driver
Clarity LIMS User Base Growing
Tuesday, May 21, 2013
GenoLogics and Illumina Sign Deal
GenoLogics has signed a worldwide co-selling agreement with Illumina.
Wednesday, February 01, 2012
GenoLogics Raises $8 Million Strategic Financing Round Led by Illumina
Funds to accelerate product development and expand sales and marketing reach
Tuesday, December 27, 2011
EdgeBio Deploys the GenoLogics LIMS for Next-Generation Sequencing
LIMS is designed to provide the scalability, adaptability and usability features necessary for mainstream adoption of the most advanced sequencing technologies while supporting existing genotyping platforms
Tuesday, November 29, 2011
GenoLogics Releases White Paper on Increasing NGS Genomics Lab Throughput
GenoLogics has releases a white paper on how to improve lab efficiency and increase throughput with a pre-configured Laboratory Information Management System (LIMS)
Saturday, September 17, 2011
Enabling the USC Epigenome Center to keep up with Constantly Changing Next Generation Sequencing Technology and Rising Throughput
GenoLogics is enabling the USC Epigenome Center to accelerate their research, improve communications with customers and collaborators, while their lab scales with quickly changing genomics technologies and throughput.
Wednesday, November 17, 2010
University of Southern California Epigenome Center Chooses new System to Provide Next-Gen Data Management Solution
GenoLogics have announced that the Epigenome Center at the University of Southern California (USC) has purchased its lab and data management solution, Geneus, to manage its genomics and next generation sequencing data.
Tuesday, November 16, 2010
Queensland Centre for Medical Genomics in Australia Chooses LIMS for Next-Generation Sequencing Sample Tracking
The Queensland Centre for Medical Genomics (QCMG) has chosen GenoLogics Geneus, a LIMS system that is built to enable genomics research. Geneus will help them to manage the sequencing data produced by the 11 Applied Biosystems SOLiDTM systems, currently in use in the lab.
Tuesday, November 16, 2010
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Emerging Model of Cancer
Cancer acts cooperatively, making individual decisions but acting in unison; this insight is being used to create a computer model of cancer.
Biological Barcodes Using CRISPR
Using genome editing tools, researchers are getting closer to understand differentiation of various cell types during development.
Controlling DNA Repair
Scientists discover that DNA repair outcomes following CRISPR-Cas9 cleaving are non-random and can be harnessed to produce desired effects.
Demonstrating LNP Delivery of CRISPR Components
Intellia has presented data demonstrating in vivo gene editing ising liquid nanoparticles (LNPs) to deliver CRISPR/Cas9.
Decades Old Chemicals Linked to Current Increased Autism Risk
The chemcials - organochlorines - were banned in the US in 1977 but their side effects are still being seen.
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Enzyme that Triggers Cell Demise in ALS Identified
Scientists from Harvard have identified a key instigator of nerve cell damage in people with amyotrophic lateral sclerosis (ALS).
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!